Published in Infect Immun on February 23, 2009
Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect Immun (2010) 0.93
Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Malar J (2010) 0.92
Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera. Infect Immun (2015) 0.81
B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines. Clin Dev Immunol (2013) 0.77
A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119. Sci Rep (2016) 0.75
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
Regulated portals of entry into the cell. Nature (2003) 15.33
Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg (2004) 8.13
Malaria. Lancet (2005) 7.37
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem (2002) 6.01
The phagosome proteome: insight into phagosome functions. J Cell Biol (2001) 4.23
A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol (2001) 3.86
Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes. Biophys J (2001) 3.68
Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol (2001) 3.51
High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell (2000) 3.37
The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med (2000) 2.80
A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat Cell Biol (2002) 2.48
Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci (2004) 2.36
Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science (1990) 2.33
Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol (1997) 2.25
Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis (2007) 1.79
Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol (2003) 1.60
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J Immunol (2007) 1.54
Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol (2005) 1.53
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol (2006) 1.45
Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy. Mol Biochem Parasitol (2001) 1.40
A fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophages. J Immunol Methods (1983) 1.28
Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem (2000) 1.26
Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. J Immunol (1996) 1.22
Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol (2004) 1.09
Malaria vaccines. Evaluation and implementation. Acta Trop (2005) 1.08
Biological applications of protein transduction technology. Trends Biotechnol (2003) 1.07
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood (2003) 1.05
Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect Immun (2002) 1.00
Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility. Invest Ophthalmol Vis Sci (1993) 0.97
Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J Immunol (2003) 0.96
Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria. Microbes Infect (2005) 0.96
A critical reassessment of penetratin translocation across lipid membranes. Biophys J (2005) 0.96
Floating cholera toxin into epithelial cells: functional association with caveolae-like detergent-insoluble membrane microdomains. Int J Med Microbiol (2000) 0.93
Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine. Microbes Infect (2008) 0.87
The immunological challenges of malaria vaccine development. Expert Opin Biol Ther (2007) 0.86
A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells. Biochem Biophys Res Commun (1997) 0.83
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. Vaccine (2002) 1.16
HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin. J Hepatol (2005) 1.15
Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am J Trop Med Hyg (2005) 1.13
Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. Cytometry A (2005) 1.13
Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans. Infect Immun (2013) 1.03
Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area. PLoS One (2012) 1.00
Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect Immun (2002) 1.00
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS (2010) 0.99
Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis (2005) 0.99
Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria. Microbes Infect (2005) 0.96
Malaria-related anaemia: a Latin American perspective. Mem Inst Oswaldo Cruz (2011) 0.95
Hepatitis C virus infection acquired in childhood. Eur J Pediatr (2007) 0.95
Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. Vaccine (2004) 0.94
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C. J Antimicrob Chemother (2008) 0.93
Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein. Int J Parasitol (2008) 0.90
Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature. Hum Pathol (2006) 0.89
The dimeric structure and the bivalent recognition of H3K4me3 by the tumor suppressor ING4 suggests a mechanism for enhanced targeting of the HBO1 complex to chromatin. J Mol Biol (2010) 0.88
Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine. Microbes Infect (2008) 0.87
Regulation of the microRNA processor DGCR8 by the tumor suppressor ING1. Cancer Res (2010) 0.87
The tumor suppressor ING1 contributes to epigenetic control of cellular senescence. Aging Cell (2010) 0.86
Crystal structure of inhibitor of growth 4 (ING4) dimerization domain reveals functional organization of ING family of chromatin-binding proteins. J Biol Chem (2012) 0.85
Infant neurocognitive development is independent of the use of iodised salt or iodine supplements given during pregnancy. Br J Nutr (2013) 0.85
Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK. Virus Res (2007) 0.85
Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome. Clin Transplant (2009) 0.83
Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate. Vaccine (2010) 0.83
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation. Antivir Ther (2009) 0.83
Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? Nephron Clin Pract (2005) 0.82
ING proteins in cellular senescence. Curr Drug Targets (2009) 0.82
Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation (2005) 0.82
A hybrid multistage protein vaccine induces protective immunity against murine malaria. Infect Immun (2012) 0.81
Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome? Clin Transplant (2006) 0.81
Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization. Transplantation (2006) 0.81
Comparison of pathological changes and viral antigen distribution in tissues of calves with and without preexisting bovine viral diarrhea virus infection following challenge with bovine herpesvirus-1. Am J Vet Res (2013) 0.78
Tactical knowledge in tennis: a comparison of two groups with different levels of expertise. Percept Mot Skills (2012) 0.77
Analysis of the relationship between the amount of training and cognitive expertise. A study of young volleyball players. J Strength Cond Res (2013) 0.77
Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000. HIV Clin Trials (2002) 0.76
The magnitude of week 4 HCV RNA decay on pegylated interferon/ribavirin accurately predicts virological failure in patients with genotype 1. Antivir Ther (2007) 0.76
Effectiveness of a video-feedback and questioning programme to develop cognitive expertise in sport. PLoS One (2013) 0.75
Heyde's Syndrome. Rev Esp Cardiol (2010) 0.75
Analysis of declarative and procedural knowledge in volleyball according to the level of practice and players' age. Percept Mot Skills (2012) 0.75
The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus. Hum Pathol (2004) 0.75
Using archetypes for defining CDA templates. Stud Health Technol Inform (2012) 0.75
A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer. Clin Transl Oncol (2008) 0.75
[Conjunctival rhinosporidiois diagnosed in a biopsy specimen]. Rev Chilena Infectol (2014) 0.75